Tuesday, 18 April 2017

New Report Covers Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2017

Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Continuous Glucose Monitoring Systems currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Continuous Glucose Monitoring Systems pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.
- Extensive coverage of the Continuous Glucose Monitoring Systems under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Continuous Glucose Monitoring Systems and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Continuous Glucose Monitoring Systems under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Companies Mentioned
A. Menarini Diagnostics S.r.l. Abbott Diabetes Care, Inc. Advanced Biosensors-Ohio, Llc Advanced Medical Electronics Corporation Arkal Medical, Inc. Bio-Impedance General Ltd. Biorasis, Inc. Biovotion AG CALISTO MEDICAL, INC. Cardiff University City, University of London Columbia University ConvaTec Group Plc Cyber Medical Ltd. Debiotech SA DexCom Inc DirectSens GmbH Echo Therapeutics Inc Ecole Polytechnique Federale de Lausanne eLutions Integrated Systems, Inc. EyeSense GmbH Flowsion A/S Gili Medical Ltd Globe Medical Tech Inc GlucoLight Corporation Glucometrix AG Glucosense Diagnostics Ltd GlucoSet AS Glucovation Inc GluMetrics Inc GlySens Inc GlySure Ltd G-Sense Ltd. Guided Therapeutics Inc iGlyko, Inc. Indigo Diabetes NV Institute of Biomedical Engineering (ISIB-CNR) Insulet Corp Integrated Medical Group of Irvine Integrity Applications Ltd Invivomon Inc Invivosense ASA iSense Corporation Massachusetts Institute of Technology MASTInc Medella Health Inc. Medical Wireless Sensing Ltd Medtronic plc Mellitor Ltd. Microchips Biotech Inc mobiLIFE Nemaura Medical Inc Northwestern University NovioSense BV Optiscan Biomedical Corp PositiveID Corp Prediktor AS Profusa, Inc. San Meditech (Huzhou) Co., Ltd. Senseonics, Incorporated SensiVida Medical Technologies, Inc. Sentek Group, Inc. Senzime AB Singapore Biomicro Pte Ltd Tenax Therapeutics Inc Terumo Corp Texas A&M University Ultradian Diagnostics LLC University of Bath University of California Berkeley University of California Irvine University of California San Diego University of South Florida University of Texas at Arlington Vytrace, Inc. Zyvex Corporation
Debora White
Manager - Marketing
Ph: +1-888-789-6604
ReportstackMarket Research


Post a Comment

Subscribe to Post Comments [Atom]

<< Home